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Abstract
Dystroglycan (DG) is a highly versatile cell surface molecule that provides a molecular link between the extracellular matrix (ECM) and
the actin-based cytoskeleton. Encoded by a single gene, DG is posttranslationally processed to form -DG, a peripheral protein identified
as the cellular receptor for lymphocytic choriomeningitis virus (LCMV) and Lassa fever virus (LFV), and the membrane-spanning subunit
-DG. The link of -DG to the actin-based cytoskeleton and its association with the cellular signal transduction network suggest that it may
function as an essential cofactor for the activity of -DG as a virus receptor. To address this issue, we constructed a deletion mutant lacking
the cytoplasmic domain of -DG and a C-terminal fusion between -DG and the transmembrane domain of PDGF receptor. Both mutants
were functional as virus receptors, indicating that -DG does not act as a cofactor with -DG for arenavirus binding and entry. These
observations are in agreement with the fact that LCMV infection is independent from the structural integrity of the actin-based cytoskeleton
and suggest that -DG functions primarily in the attachment of arenaviruses to the cell surface.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Lymphocytic choriomeningitis virus (LCMV) is the pro-
totypic member of the arenavirus family (Buchmeier et al.,
2001). The bisegmented negative-strand genome of LCMV
consists of two single-stranded RNA species. The larger
segment named L encodes the virus polymerase (L) and a
small zinc finger motif protein (Z), while the smaller RNA
segment (S) encodes the virus nucleoprotein (NP) and gly-
coprotein precursor (GPC). GPC is processed into the pe-
ripheral glycoprotein GP1 and the transmembrane glycop-
rotein GP2 by the protease SKI-1/S1P (Lenz et al., 2001;
Beyer et al., 2003; Kunz et al., 2003). GP1 is implicated
in receptor binding (Parekh and Buchmeier, 1986, Borrow
and Oldstone, 1992) and GP2 is structurally similar to the
fusion active membrane proximal portions of the glycopro-
teins of other enveloped viruses (Gallaher et al., 2001).
Upon receptor binding, arenavirus virions are internalized
by uncoated vesicles and released into the cytoplasm by a
pH-dependent membrane fusion step (Borrow and Old-
stone, 1994; Di Simone et al., 1994; Di Simone and Buch-
meier, 1995).
The cellular receptor for LCMV and the human pathogen
Lassa fever virus (LFV) has been identified as -dystrogly-
can (-DG) (Cao et al., 1998). DG is a ubiquitously ex-
pressed, highly versatile cell surface receptor that provides
a molecular link between the extracellular matrix (ECM)
and the actin-based cytoskeleton and plays a critical role in
cell-mediated assembly of basement membranes (reviewed
by Henry and Campbell, 1999; Winder, 2001; Michele and
Campbell, 2003). In vertebrates DG is encoded by a single
gene (DAG1) and is posttranslationally processed to form
-DG, a peripheral protein, and the membrane protein
-DG (Ibraghimov-Beskrovnaya et al., 1992). An N-termi-
nal signal peptide targets DG into the endoplasmatic retic-
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ulum. DG is then cleaved by an unidentified protease after
amino acid 653 into -DG and -DG. -DG is secreted and
held at the extracellular face of the membrane via nonco-
valent associations with the extracellular portion of -DG,
which is mediated by residues 550–585 of the C-terminal
region of -DG (Sciandra et al., 2001). -DG undergoes
high-affinity interactions with ECM proteins containing
LamG domains, such as laminin, agrin, neurexin, and per-
lecan and is noncovalently associated with the membrane
spanning -DG. Within the dystrophin glycoprotein com-
plex of skeletal muscle, -DG binds to dystrophin. In tis-
sues outside of skeletal muscle and brain, full-length dys-
trophin is replaced by truncated dystrophin variants and the
closely related molecule utrophin. Dystrophin and utrophin
provide a physical link to the actin-based cytoskeleton and
are associated with further cytoskeletal components, e.g.,
the syntrophins. Other molecules that bind the cytoplasmic
tail of -DG include the signal transduction molecule grb2
and the focal adhesion kinase FAK (Yang et al., 1995;
Cavaldesi et al., 1999). The link of -DG to the actin-based
cytoskeleton and its association with the cellular signal
transduction network suggest that it may participate as a
cofactor for the receptor function of -DG.
The present study addresses the role of -DG in the
function of -DG as arenavirus receptor. Biochemical char-
acterization of -DG deletion mutants demonstrated that
-DG is not essential for biosynthesis and transport of
-DG. A fusion protein of -DG with the transmembrane
domain of platelet-derived growth factor (PDGF) receptor
was functional as a receptor for LCMV, indicating that
-DG and its cytoplasmic binding partners are dispensable
for the function of -DG as a virus receptor. These findings
suggest that -DG functions primarily in the attachment of
arenaviruses to the cell surface.
Results
-DG is not essential for the biosynthesis and transport
of -DG
To study a possible role of -DG for the biosynthesis,
cell surface expression, and receptor function of -DG, we
made the following deletion mutants: DGC (782–895),
which lacks the cytoplasmic domain of -DG, and -DG-
PDGF, a C-terminal fusion between -DG and the trans-
membrane domain of PDGF receptor (Fig. 1A). The
mutants were inserted into the E1 region of replication-
deficient adenovirus (AdV) vectors. For initial characteriza-
tion, DG (/) mouse embryonic stem (ES) cells were
infected with the AdV vectors containing the -DG deletion
mutants and wild-type DG. Cells were solubilized 48 h after
AdV infection, and total protein was isolated and subjected
to Western blot analysis. -DGPDGF was expressed at high
level, as assessed by detection of the myc epitope (Fig. 1B).
Clearly present were high levels of the -DG part of wild-
type DG. For the analysis of virus binding, DG (/) ES
cells were infected with the AdV vectors containing the
-DG deletion mutants, wild-type DG, and green fluores-
cent protein (GFP). Cell lysates were prepared 48 h after
transfection and subjected to affinity purification using the
lectin jacalin that binds to the mucin-type glycans that are
present on -DG (Kunz et al., 2001). For the analysis of
virus binding, jacalin-bound glycoproteins were subjected
to virus overlay protein binding assay (VOPBA) with
LCMV clone-13 (cl-13) (Fig. 1C). Strong binding of LCMV
cl-13 to DGC, -DGPDGF, and wild-type DG, but not to
proteins isolated from GFP transfectants, indicated that
-DG is not essential for the biosynthesis of -DG that is
functional in virus binding. The very broad appearance of
the processed -DG in the mutants -DGPDGF and DGC,
as well as wild-type DG, suggests a similar, high degree of
carbohydrate addition to all three DG variants.
Recent reports have demonstrated the release of a soluble
form of -DG from some cultured cell types such as RT4
schwannoma cells (Matsumura et al., 1997) and bovine
aortic endothelial cells (Shimizu et al., 1999), as well as
from CHO cells expressing heterologous DG (Holt et al.,
2000), suggesting some instability of the /-DG complex
in these cell types. We addressed the release of soluble
-DG from DG (/) ES cells transfected with AdV vec-
tors containing the -DG deletion mutants, wild-type DG,
and green fluorescent protein (GFP). Forty-eight hours post-
transfection, total cell lysates and conditioned medium were
subjected to affinity precipitation with wheat germ aggluti-
nin (WGA) agarose (Holt et al., 2000). WGA-bound glyco-
proteins were tested for the presence of -DG by VOPBA
with LCMV cl-13 and for the presence of -DG by Western
blot (Fig. 1D). Comparable amounts of -DG were detected
in WGA precipitates of lysates from cells expressing -DG-
PDGF, DGC, and wild-type DG. In contrast, -DG was
detected only in the conditioned culture medium of cells
expressing DGC and wild-type DG but not in conditioned
supernatants of cells expressing the fusion protein -DGP-
DGF. The shedding of -DG from cells expressing DGC
and wild-type DG is reminiscent of the situation in other
cultured cells types and in cells expressing heterologous DG
(Holt et al., 2000). The absence of -DG from conditioned
supernatants of cells expressing -DGPDGF (Fig. 1D) and
the presence of the myc-epitope in -DGPDGF derived
from total cell lysates (Fig. 1B) suggest that no significant
cleavage occurs between the -DG moiety and the myc
epitope, which is localized N-terminal of the PDGF receptor
transmembrane domain. As expected, -DG was detected
only in the cell lysate of cells transfected with wild-type
DG. The additional -DG-reactive band of 140–150 kDa in
the Westen-blot of Fig. 1D most likely corresponds to the
uncleaved DG precursor, recently described in cells over-
expressing DG (Holt et al., 2000). Its absence in the
VOBPA suggests incomplete modification of the precursor
which reduces its virus binding affinity.
To assess the requirement of -DG for transport of -DG
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to the cell surface, we investigated the cellular distribution
of -DGPDGF expressed in COS1 cells by immunofluores-
cence microscopy. For comparison with an intracellular
protein, cells were transfected with the NP of LCMV
ARM53b. As an example for membrane glycoprotein, we
used a 3 transcriptional fusion of CD46 membrane protein
with EGFP (Shestopalov and Bassnett, 1999). Forty hours
posttransfection, cells were fixed using 2% (wt/vol) form-
aldehyde and 0.1% (wt/vol) glutaraldehyde to obtain com-
plete immobilization of membrane proteins without perme-
abilization (Dubreuil et al., 1996). In nonpermeabilized
cells, strong staining for -DGPDGF was detected with an
anti-myc antibody (Figs. 2a and e). Lack of permeabiliza-
tion was verified by the absence of significant staining for
the intracellular LCMVNP (data not shown). Upon treat-
ment with 0.1% (wt/vol) saponin, which permeabilizes cell
Fig. 1. Expression of -DG deletion mutants in DG (/) ES cells. (A) Schematic representation of the -DG deletion mutants. The putative N-terminal
subdomains, amino acids 30–160 and 181–316 (white), the mucin-related central domain 317–485 (black), and the C-terminal globular domain 486–653
(gray) of -DG are indicated. Amino acids 654–895 represent -DG with the transmembrane domain (dark box). The myc epitope at the C-terminus of -DG
and the PDGF receptor transmembrane domain (PDGF tmd) in -DG PDGF are indicated. (B) Expression of the DG deletion mutants. DG (/) ES cells
were infected with AdV vectors containing the -DG deletion mutants or wild-type DG. After 48 h, total protein was isolated, separated by SDS–PAGE,
and transferred to nitrocellulose. The blots were probed with antibodies anti-myc (upper panel) and anti--DG (lower panel) using ECL for detection.
Molecular masses are indicated in kilodaltons (kDa). (C) Binding of LCMV cl-13 to -DG deletion mutants: DG (/) ES cells were infected with AdV
containing the -DG deletion mutants, wild-type DG, and GFP. As a positive control, DG (/) ES cells were used. After 48 h, cells were lysed and lysates
subjected to jacalin affinity chromatography. Jacalin-bound glycoproteins were separated by SDS–PAGE, transferred to nitrocellulose, and subjected to
VOPBA with 107 PFU/ml of LCMV cl-13. Bound virus was detected with mAb WE33 and WE36 against LCMVGP using ECL. (D) Detection of the
secretion of -DG into the cell culture medium; 48 h posttransfection, conditioned cell culture medium (medium) and detergent extracts (cells) of cells
transfected with AdV vectors expressing -DGPDGF (1), DGC (2), DG wild-type (3), and GFP (4) were subjected to WGA affinity chromatography.
WGA-bound glycoproteins were eluted, separated by SDS–PAGE, blotted to nitrocellulose, and subjected to VOPBA with LCMV cl-13 or Western-blot
analysis using an anti--DG antibody.
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membranes but does not affect the overall cytoarchitecture,
staining for -DGPDGF (Fig. 2b, f) resembled that in non-
permeabilized cells (Figs. 2a and e), and, as expected,
strong specific intracellular staining was observed for
LCMVNP (Figs. 2c and g). The CD46-EGFP fusion pro-
tein, detected by direct fluorescence excitation, was found
predominantly in the plasma membrane (Figs. 2d and h).
The strong staining for -DGPDGF in nonpermeabilized
cells and the similarity of its cellular distribution with the
membrane protein CD46-EGFP suggest efficient cell sur-
face expression of the -DG deletion mutant.
For a more quantitative assessment of cell surface ex-
pression of both -DG mutants, the presence of recombi-
nant proteins in the plasma membrane of transfected cells
was determined by a cell surface biotinylation assay
(Gonzalez-Dunia et al., 1997). DG (/) ES cells were
infected with the AdV vectors carrying the -DG deletion
mutants and wild-type DG. Forty hours after AdV-mediated
gene transfer, cell surface proteins were specifically labeled
by the membrane-impermeable biotinylation reagent NHS-
X-biotin. Biotin-labeled proteins were subsequently recov-
ered by incubating total cell lysates with streptavidin–aga-
rose. VOPBA analysis revealed similar amounts of -DG
exposed at the surface of cells transfected with DGC and
wild-type DG but reduced cell surface expression of -DG
PDGF (Figs. 3A and B). The validity of this approach was
shown by negligible biotin-labeling of the intracellular pro-
tein -tubulin (Fig. 3A).
Together, these data indicate that the intracellular do-
main or -DG is not required for biosynthesis and trans-
port of -DG. The lower cell surface expression level of
-DGPDGF when compared to wild-type DG is most likely
not due to increased release of -DG from -DG PDGF-
transfected cells, as no significant shedding of -DG was
observed (Fig. 1D), but may reflect impaired transport of
-DG PDGF or a reduced half-life in the membrane.
-DG is dispensable for the LCMV receptor
function of DG
Since the interaction of -DG with the cytoskeleton or
other binding partners may influence viral binding and/or
internalization, we tested the -DG deletion mutants for
reconstitution of susceptibility to virus infection in nonper-
missive cells. DG (/) ES cells were infected with the
AdV vectors carrying the -DG deletion mutants and wild-
type DG. As negative controls we used the AdV containing
the -DG deletion mutant DGH (H30-S485) which is
deficient in binding to LCMV (Kunz et al., 2001) or a vector
containing a -galactosidase transgene (LacZ). Forty-eight
hours after AdV-mediated gene transfer, transgene expres-
sion was verified by VOBPA and Western blot analysis
(Fig. 4A). Cells in parallel samples were infected with
LCMV cl-13 48 h after infection with the AdV vectors.
LCMV infection of cells was assessed after 12, 24, and 48 h
by immunofluorescence staining for LCMVNP. Infection of
DG (/) ES cells with AdV vectors carrying the mutants
DGC, -DGPDGF, and wild-type DG, but not DGH or
LacZ, made these cells susceptible to LCMV infection (Fig.
4B). These data indicate that -DG is not essential for entry
of LCMV while -DG is. The reduced cell surface expres-
sion levels of -DGPDGF when compared to wild-type
DG, as detected by cell surface biotinylation assay (Fig. 3),
Fig. 2. Localization of -DGPDGF in mammalian cells. COS1 cells were transiently transfected with -DGPDGF (a, b, e, f), LCMVNP (c, g), and
CD46-EGFP (d, h) using Lipofectamine; 24 h after transfection, cells were transferred to LabTek tissue culture chamber slides. After 24 h, cells were fixed
and samples b/f and c/g permeabilized with saponin. -DGPDGF was detected using an anti-myc antibody (a, b: fluorescence optics; e, f: phase optics).
LCMVNP was detected with mAb 113 anti-LCMVNP (c: fluorescence optics; g: phase optics). Primary antibodies were detected with rhodamine-X (red)-
or FITC (green)-coupled anti-mouse IgG secondary antibody. The CD46-EGFP fusion protein was detected by direct immunofluorescence excitation using
the FITC channel (d: fluorescence optics; h: phase optics). Bar  20 m.
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has apparently no significant effect on susceptibility to virus
infection.
Discussion
The present study shows that -DG is not required for
the biosynthesis and transport of -DG and demonstrates
that -DG does not act as a cofactor with -DG for arena-
virus binding and entry.
The link of -DG to the actin-based cytoskeleton and its
association with the cellular signal transduction network
(Henry and Campbell, 1999; Winder, 2001) suggest that it
may function as an essential cofactor for the activity of
-DG as a virus receptor. To address this issue, we con-
structed a deletion mutant lacking the cytoplasmic domain
of -DG (DGC) and a C-terminal fusion between -DG
and the transmembrane domain of PDGF receptor (-DG
PDGF). Biochemical characterization of these mutants ex-
pressed in DG (/) ES cells revealed that their -DG
moieties were functional in virus binding and transport to
the cell surface occurred. Quantitative assessment of the cell
surface expression levels of the DG variants by cell surface
biotinylation revealed a significant reduction in surface ex-
pression of -DGPDGF when compared to wild type. Since
no significant shedding of -DG from cells expressing
-DGPDGF was observed, the reduced cell surface expres-
sion levels of -DGPDGF is most likely not due to in-
creased release of -DG from -DGPDGF-transfected cells.
The reduced cell surface expression of -DGPDGF may be
either due to a reduced half-life in the plasma membrane
and/or impaired transport to the cell surface when compared
to wild-type DG.
The function of the -DG deletion mutants as virus
receptors was tested by their ability to reconstitute LCMV
infection of DG (/) ES cells. Despite its lack of -DG
and its partially reduced cell surface expression level, -DG
PDGF was functional as a virus receptor, indicating that
-DG is dispensable and not required for the receptor func-
tion. Hence, association with neither the actin-based cy-
toskeleton nor with signal transduction molecules that in-
teract with -DG is needed for the virus receptor function of
DG. These observations are in agreement with another re-
port that LCMV infection was independent from the struc-
tural integrity of the actin-based cytoskeleton (Borrow and
Oldstone, 1994). Taken together, these findings suggest that
-DG functions primarily in the attachment of arenaviruses
to the cell surface. Binding of the viral GP to -DG may be
sufficient for the subsequent pH-induced conformational
changes that result in the exposure of a fusion peptide-
related structure of GP2. Alternatively, initial attachment of
virions to target cells mediated by -DG may be followed
by the interaction of the viral GP with another molecule on
the cell surface, which may then mediate internalization.
Last, although -DG is not required for virus receptor
Fig. 3. Detection of -DG deletion mutants at the cell surface. (A) Cell surface biotinylation assay: DG (/) ES cells were infected with AdV vectors
containing the -DG deletion mutants and wild-type DG (triplicates), and GFP (). After 40 h, cell surface protein was labeled with biotin-X-NHS and the
surface-labeled cells were subsequently lysed; 50% of the lysates were subjected to affinity precipitation with streptavidin–agarose. From the residual 50%
of lysates total protein was isolated. Streptavidin–precipitated proteins (biotinylated protein) and total protein were separated by SDS–PAGE and transferred
to nitrocellulose. Blots were subjected to VOPBA with LCMV cl-13 (upper panel) as described in Fig. 1C and analyzed by Western blot using mAb DM1A
anti--tubulin (lower panel). Primary antibodies were detected with peroxidase-conjugated secondary antibodies using ECL for detection. Positions of -DG
and -tubulin (-tu) are indicated. (B) Quantitative analysis of cell surface expression of -DG PDGF, DGC, DG wild-type by densitometry. X-ray films
shown in (A) were scanned with a Storm 860 densitometer and the relative surface expression rates (SERs) were calculated as SER  Icell surface/Itotal protein,
with Icell surface  intensity of the signal of the biotinylated protein and Itotal protein  intensity of the signal of the total protein, in arbitrary densitometric units
(n  3  SD). *Statistically significant differences.
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function, it may still play a role in virus–host cell interac-
tion. The association of -DG with signal transduction
molecules such as grb2 and FAK (Yang et al., 1995; Cav-
aldesi et al., 1999) suggests a role of DG in cellular signal-
ing involved in differentiation, growth, and homeostasis.
However, the exact role of DG-associated signaling in the
host cell is currently not known and recent studies suggest
a high degree of complexity of DG-mediated signaling,
involving multiple pathways. For example, disruption of
laminin–DG interactions in muscle cells resulted in a re-
duced phosphorylation of protein kinase B (AKT) and its
downstream effector glycogen synthase kinase (GSK)-3,
suggesting a link between DG and the phosphoinositide
3-kinase (PI3K)/protein kinase B (AKT) pathway (Langen-
bach and Rando, 2002). Depletion of -DG in an animal
model for skeletal muscle atrophy led to decreased activities
in the small GTPases H-Ras, Rac1, and Cdc42, supporting
a link between DG and the GTPases (Chockalingam et al.,
2002). It is conceivable that binding of LCMV virions to the
surface of target cells may induce clustering of /-DG
complexes, resulting in activation of -DG-associated sig-
nal transduction molecules, a possibility we plan to inves-
tigate. Activation of cellular signal transduction pathways
upon virus–receptor binding may influence target cell func-
tion and contribute to viral pathogenesis.
Materials and methods
Proteins and antibodies
Monoclonal antibody (mAb) to LCMV 113 (anti-LCM-
VNP) and mAb 83.6 anti-LCMVGP2, WE33 (anti-LCM-
VGP2), and WE36 (anti-LCMVGP1) have been described
(Buchmeier et al., 1981; Weber and Buchmeier, 1988), as
has polyclonal antibody AP83 against -DG (Williamson et
al., 1997). Polyclonal anti-influenza hemagglutinin epitope
(HA) antibody Y11 and mAb 9E10 anti-myc epitope were
purchased from St. Cruz Biotechnology (St. Cruz, CA).
mAb DM1A anti--tubulin was purchased from Sigma.
FITC- and rhodamine-X-conjugated anti-mouse IgG were
from Jackson Immuno-Research Laboratory (West Grove,
PA). HRP-conjugated anti-mouse and anti-rabbit IgG were
from Pierce Chemical Co. (Rockford, IL).
Viruses and cells
LCMV clone-13 is a plaque-purified variant of ARM53b
derived from spleen cells of an adult BALB/WEHI mouse
persistently infected since birth with ARM53b (Ahmed et
al., 1984). Seed stocks of all viruses were prepared by
growth in BHK-21 cells. Purified virus stocks were pro-
Fig. 4. Reconstitution of susceptibility to virus infection in DG (/) ES cells. (A) Verification of transgene expression. DG (/) ES cells were infected
with AdV vectors containing wild-type, deletion mutants of -DG, DGH, or a -galactosidase reporter gene (LacZ) at a MOI of 10. Forty-eight hours after
AdV-mediated gene transfer, total cell protein was isolated and separated by SDS–PAGE. Total protein derived from cells expressing -DG PDGF, DGC,
DG wild-type, and LacZ were probed by VOPBA with LCMV cl-13 (VOPBA) as described in Fig. 1. Expression of DGH was verified by Western blot
(anti-HA). Total protein from cells transfected with DGH and LacZ was separated by SDS–PAGE, blotted to nitrocellulose and probed with an anti-HA
antibody using ECL for detection. (B) Reconstitution of susceptibility to virus infection. DG (/) ES cells infected with AdV vectors in parallel to the cells
examined in (A) were infected with LCMV clone-13 (MOI  3) 48 h after AdV-mediated gene transfer. Infection levels were assessed after 12 (black bars),
24 (gray bars), and 48 h (white bars) by detection of the presence of LCMVNP by using mAb 113 anti-LCMVNP and a FITC-labeled secondary antibody.
For each mutant, 100 cells were analyzed and green fluorescing cells scored as positive (n  3; SD). DG (/) ES cells were used as a positive control.
Cell not infected with LCMV (mock) did not show any detectable LCMVNP staining above background.
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duced and virus titers determined as described (Dutko and
Oldstone, 1983; Ahmed et al., 1984).
DG (/) and DG (/) mouse ES cells were main-
tained as described (Smelt et al., 2001). Reconstitution of
susceptibility to LCMV infection by AdV-mediated gene
transfer was performed as described in Cao et al. (1998).
AdV vector was applied in a multiplicity of infection (MOI)
of 10 and cells were incubated for 48 h prior to infection
with LCMV. LCMV was used in a MOI of 3 and infection
determined after 12, 24, and 48 h. Infected cells were
determined by immunofluorescence staining for LCMVNP
(Smelt et al., 2001).
Construction of DG deletion mutants and generation of
adenoviral vectors
For the construction of -DGPDGF, the fragment Fdf-PD
was amplified by PCR on the full-length rabbit DG cDNA
(Ibraghimov-Beskrovnaya et al., 1992) cloned into the expres-
sion vector pDisplay (Invitrogen). Fdf-PD was digested with
SacI and SalI and inserted into DG pDisplay. The mutant was
verified by double-strand DNA sequencing. The construct
DGC, containing the deletion 782–895 in -DG, was
kindly provided by Jane Lee and Michael Henry (University of
Iowa): Fdf: 5ACCACCGCCGGCGTGCCCCGCGGGGG-
A3; FD: 5ATTGTCGACGCCGCGGGTGATGGTCTG3.
The cDNA fragments encoding the -DG deletion mu-
tants were excised from the pDisplay-based expression con-
structs and inserted into the shuttle plasmid pAdV/RSV
(Kunz et al., 2001). Replication-deficient AdV vectors were
generated by in vivo recombination as described (Bett et al.,
1994). Twofold plaque-purified isolates were amplified, pu-
rified by CsCl gradient centrifugation, and screened for
protein expression by Western blot analysis.
Immunoblotting and VOPBA
Total protein and jacalin-bound glycoproteins (Kunz et
al., 2001) as well as WGA-bound glycoproteins (Holt et al.,
2000) were isolated from ES cells, separated by gel elec-
trophoresis, and transferred to nitrocellulose. After blocking
in 5% (wt/vol) skim milk powder in PBS, membranes were
incubated with the primary antibody (polyclonal rabbit an-
tibody AP83 against -DG in a dilution of 1:500, polyclonal
rabbit antibody Y11 anti-HA 1: 500, mAb 9E10 anti-myc:
1: 100, and mAb DM1A anti--tubulin 1: 1000) in 2%
(wt/vol) skim milk powder, PBS for 12 h at 6°C. After
several washes in 0.1% (wt/vol) Tween-20, PBS (PBST),
the secondary antibodies, goat anti-rabbit IgG or goat anti-
mouse IgG coupled to peroxidase (Roche), were applied
1:5000 for 1 h at room temperature. Blots were developed
using Super Signal West Pico enhanced chemiluminescence
(ECL) substrate (Pierce) and signals were recorded on au-
toradiographic film (Kodak, Rochester, NY). VOPBA was
performed as described (Cao et al., 1998) using 107 pfu/ml
LCMV cl-13 purified by ultracentrifigation on a renografin
gradient.
Biotinylation of cell surface proteins
For cell surface biotinylation assay, DG (/) mouse
ES cells (4  105 cells/well) were plated in gelatin-pre-
treated six-well plates. After a 24-h incubation, AdV vectors
were applied in a MOI of 10 and cells incubated for 40 h
prior to cell surface labeling. Surface-specific biotinylation
and isolation of biotinylated proteins were accomplished as
described in Gonzalez-Dunia et al. (1997). Densitometric
analysis was performed with a Storm 860 scanner using
ImageQuant software.
Immunofluorescence staining
COS1 cells (2  105 per well of a six-well plate) were
transfected with the expression constructs -DGPDGF
pDisplay, LCMVNP pcAGGS (Lee et al., 2000), and
pFusN115 that contains a C-terminal transcriptional fusion
of CD46 with EGFP (Shestopalow and Bassnett, 1999)
using Lipofectamine (GIBCO BRL) resulting in 40–50%
transfection efficiency. Cells were maintained for 24 h after
transfection, washed, briefly trypsinized, and suspended in
medium. After cell count in the presence of trypan blue,
5000 live cells were transferred to each well of poly-L-
lysine-pretreated eight-well LabTek tissue culture glass
chamber slides (Nunc). After 24 h, cells were fixed with 2%
(wt/vol) formaldehyde and 0.1% (wt/vol) glutaraldehyde as
described (Dubreuil et al., 1996). Cells were washed three
times in PBS and blocked with 1% (vol/vol) FBS, PBS for
30 min. For permeabilization of cell membranes, 0.1%
(wt/vol) saponin was added to all buffers and solutions.
Primary antibodies mAb 9E10 anti-myc (1:50) and mAb
113 anti-LCMV NP (1:100) were applied for 2 h at room
temperature. Secondary antibodies, anti-mouse IgG conju-
gated to FITC (1:100) or rhodamine-X (1:200), were ap-
plied in 1% (vol/vol) FBS, PBS for 1 h at room temperature.
The CD46-EGFP fusion protein was detected by direct
immunofluorescence excitation using the FITC channel. Im-
ages were captured using a Zeiss Axiovert S100 microscope
(Carl Zeiss, Inc., Thornwood, NY) fitted with a 20 objec-
tive, an AxioCam digital camera, and an automated stage.
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